Skip to main content
Japan Tissue Engineering Co., Ltd. logo

Japan Tissue Engineering Co., Ltd. — Investor Relations & Filings

Ticker · 7774 ISIN · JP3389610001 T Manufacturing
Open in API
Filings indexed 64 across all filing types
Latest filing 2020-02-13 Interim / Quarterly Rep…
Country JP Japan
Listing T 7774

About Japan Tissue Engineering Co., Ltd.

https://www.jpte.co.jp/en/

Japan Tissue Engineering Co., Ltd. (J-TEC) is a company focused on the commercialization and industrialization of regenerative medicine. It develops, manufactures, and sells tissue-engineered medical products. The company operates through three primary business segments: the Regenerative Medicine Business, which provides its own therapeutic products such as autologous cultured cartilage and epidermis; the Custom Development & Manufacturing (CDMO) Business, offering contract services to support other developers in the field; and the LabCyte Business, which supplies cultured human tissue models for research and safety assessment purposes. J-TEC aims to establish regenerative medicine as a standard of care in healthcare.

Recent filings

Filing Released Lang Actions
四半期報告書－第22期第3四半期(令和1年10月1日－令和1年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Japan Tissue Engineering Co., Ltd., covering the third quarter of the 22nd fiscal period (October 1, 2019, to December 31, 2019). It contains detailed financial statements, management analysis, and regulatory disclosures required under the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-02-13 Japanese
四半期報告書－第22期第2四半期(2019/07/01－2019/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the second quarter of the fiscal year 2019, filed with the Tokai Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MDA), and corporate information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2019
2019-11-13 Japanese
四半期報告書－第22期第1四半期(2019/04/01－2019/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of the 22nd fiscal period (April 1, 2019 to June 30, 2019) filed by Japan Tissue Engineering Co., Ltd. It contains detailed financial statements, management analysis, and business updates, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-08-09 Japanese
有価証券報告書－第21期(平成30年4月1日－平成31年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of a 10-K annual report. It contains detailed financial indicators, company history, and business descriptions for the fiscal year ending March 31, 2019. It is a comprehensive annual filing, not an announcement or a summary. FY 2019
2019-06-26 Japanese
四半期報告書－第21期第3四半期(2018/10/01－2018/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Japan Tissue Engineering Co., Ltd., covering the third quarter of the 21st fiscal period (ending December 31, 2018). It contains detailed financial statements, management analysis, and regulatory disclosures required under the Financial Instruments and Exchange Act of Japan. As it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). 9M 2019
2019-02-14 Japanese
四半期報告書－第21期第2四半期(2018/07/01－2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis (MD&A), and business updates for the second quarter of the fiscal year ending March 31, 2019. It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2019
2018-11-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.